All in all - this webcast was mostly recycled/generic information already known, with some (new) concrete direction on agvhd FDA progression and a healthy dose of positive hints on a few of the hot irons currently in the fire.
Understand that folks are wanting immediate news on the Novartis partnership, but "a few weeks" was only stated on the 30 Apr. Hasn't even been five weeks yet. They're at the negotiating table with several big players - SI and co won't give us anything until there's ink on paper so people really need to be understanding here.
A few positive hints regarding Novartis, CHF in the webcast which was nice. What does "very near term" mean exactly for price sensitive news on Novartis? Hopefully something in the next 2-3 weeks.
Currently, two things are certain:
1. Novartis is still here
2. The rolling commentary from a few thoughtful posters this morning on the webcast was greatly appreciated
Here's to the "very near term"!
All in all - this webcast was mostly recycled/generic...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $4.794M | 4.399M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14500 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 141676 | 5 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |